A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever

• Main Authors: Kathleen A. Cashman (Author), Eric R. Wilkinson (Author), Carl I. Shaia (Author), Paul R. Facemire (Author), Todd M. Bell (Author), Jeremy J. Bearss (Author), Joshua D. Shamblin (Author), Suzanne E. Wollen (Author), Kate E. Broderick (Author), Niranjan Y. Sardesai (Author), Connie S. Schmaljohn (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lassa virus (LASV) is an ambisense RNA virus in the Arenaviridae family and is the etiological agent of Lassa fever, a severe hemorrhagic disease endemic to West and Central Africa. There are no US Food and Drug Administration (FDA)-licensed vaccines available to prevent Lassa fever. in our previous...